DSCSA Compliance: Essential Steps for Manufacturers

With the final DSCSA exemption deadline looming in May 2025, pharmaceutical manufacturers must act now to comply with the FDA’s interoperability, serialization, and traceability mandates. Non-compliance isn’t just a regulatory headache—it can cause severe disruptions, including halted product sales, costly recalls, and damaged supply chain relationships.

Continue reading DSCSA Compliance: Essential Steps for Manufacturers